Quinolone-3-Diarylethers: A New Class of Antimalarial Drug

Quinolone-3-Diarylethers: A New Class of Antimalarial Drug

ELQ-300, an investigational drug for treating and preventing malaria, shows potent transmission-blocking activity in rodent models of malaria.

Saved in:

Bibliographic Details
Main Authors:	Aaron Nilsen, Alexis N. LaCrue, Karen L. White, Isaac Forquer, R. Matthew Cross, Jutta Marfurt, Michael W. Mather, Michael J. Delves, David M. Shackleford, Fabián E. Saénz, Joanne M. Morrisey, Jessica Steuten, Tina Mutka, Yuexin Li, Grennady Wirjanata, Eileen Ryan, Sandra Duffy, Jane X. Kelly, Boni F. Sebayang, Anne‐Marie Zeeman, Rintis Noviyanti, Robert E. Sinden, Clemens H. M. Kocken, Ric N. Price, Vicky M. Avery, Íñigo Angulo‐Barturen, Marı́a Belén Jiménez-Dı́az, Santiago Ferrer, Esperanza Herreros, Laura M. Sanz, Francisco‐Javier Gamo, Ian Bathurst, Jeremy N. Burrows, Peter K. S. Siegl, R. Kiplin Guy, Rolf W. Winter, Akhil B. Vaidya, Susan A. Charman, Dennis E. Kyle, Roman Manetsch, Michael K. Riscoe
Format:	Artigo
Language:	English
Published:	2013
Online Access:	https://doi.org/10.1126/scitranslmed.3005029
Tags:	Add Tag No Tags, Be the first to tag this record!

Be the first to leave a comment!